INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,033,166 | -22.5% | 64,300 | 0.0% | 0.01% | -22.2% |
| Q2 2023 | $2,622,154 | +18.0% | 64,300 | +7.9% | 0.01% | +12.5% |
| Q1 2023 | $2,221,926 | +36.4% | 59,617 | +27.7% | 0.01% | +33.3% |
| Q4 2022 | $1,628,979 | -33.6% | 46,689 | +6.4% | 0.01% | -40.0% |
| Q3 2022 | $2,455,000 | -0.3% | 43,875 | -7.8% | 0.01% | +11.1% |
| Q2 2022 | $2,463,000 | -15.7% | 47,585 | +18.4% | 0.01% | 0.0% |
| Q1 2022 | $2,920,000 | -38.5% | 40,180 | 0.0% | 0.01% | -35.7% |
| Q4 2021 | $4,751,000 | -5.8% | 40,180 | +6.8% | 0.01% | -12.5% |
| Q3 2021 | $5,045,000 | -23.9% | 37,607 | -8.2% | 0.02% | -27.3% |
| Q2 2021 | $6,633,000 | +141.0% | 40,967 | +19.5% | 0.02% | +120.0% |
| Q1 2021 | $2,752,000 | – | 34,286 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |